Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

INCR stock hub

InterCure Ltd. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

INCRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

47.5M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

INCR

In the news

Latest news · INCR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-9.3

P25 -105.6P50 -46.5P75 -3.1

ROIC-4.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All INCR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

204

Groups with data

Currency

ILS

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001857030
Company name	InterCure Ltd.
Country	Israel
Country code	US
Cusip	M549GJ111
Employees	320
Employees Change	50%
Employees Change Percent	18.52
Enterprise value	$93M
Exchange	NASDAQ
Financial currency	ILS
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Isin	IL0011063760
Last refreshed	2026-05-10
Market cap	$47.5M
Market cap category	Nano-Cap
Price	$0.84
Price currency	USD
Rev Per Employee	264,860.41x
Sector	Healthcare
Sic	2834
Symbol	INCR
Website	https://www.intercure.co

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-23.57%
EV Sales Forward	0.43x
EV/FCF	20.31x
EV/Sales	1.1x
FCF yield	9.64%
P/B ratio	0.38x
P/S ratio	0.56x
PS Forward	0.22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-9.44%
EBITDA Margin	-3.1%
FCF margin	5.41%
Gross margin	15.06%
Gross Profit	$12.8M
Gross Profit Growth	-3.21%
Gross Profit Growth Q	-44.35%
Gross Profit Growth3 Y	-38.15%
Gross Profit Growth5 Y	3.92%
Net Income	$-11.2M
Net Income Growth Years	1%
Pretax Margin	-16.32%
Profit Margin	-13.22%
Profit Per Employee	$-35,004
ROA	-2.19
Roa5y	-0.51
ROCE	-5.36
ROE	-9.27
Roe5y	-5.71
ROIC	-4.83
Roic5y	-1.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-47.6%
Cagr3y	-28.24%
Cagr5y	-33.4%
EPS Growth Years	1
FCF Growth3 Y	-25.01%
OCF Growth3 Y	-31%
OCF Growth5 Y	16.36%
Revenue Growth	13.13x
Revenue Growth Q	3.4x
Revenue Growth Years	1x
Revenue Growth3 Y	-11.41x
Revenue Growth5 Y	32.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.37
Assets	$216.6M
Cash	$14.6M
Current Assets	$128.9M
Current Liabilities	$69.6M
Debt	$56.1M
Debt Equity	$0.45
Debt FCF	$12.24
Equity	$124.3M
Interest Coverage	-1.28
Liabilities	$92.3M
Long Term Assets	$87.7M
Long Term Liabilities	$22.7M
Net Cash	$-41.4M
Net Cash By Market Cap	$-87.16
Net Debt Equity	$0.33
Net Debt FCF	$9.04
Tangible Book Value	$55.6M
Tangible Book Value Per Share	$1.08
WACC	7.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.48
Inventory Turnover	2.01
Net Working Capital	$48.8M
Quick ratio	0.96
Working Capital	$32.1M
Working Capital Turnover	$0.47

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-18.12%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-47.58%
200-day SMA	1.2
3Y total return	-63.05%
50-day SMA	0.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-86.89%
All Time High	9.99
All Time High Change	-91.6%
All Time High Date	2021-04-13
All Time Low	0.3
All Time Low Change	179.6%
All Time Low Date	2020-03-16
ATR	0.06
Beta	0.33
Ch YTD	-7.82
High	0.89
High52	1.77
High52 Date	2025-08-11
High52ch	-52.61%
Low	0.84
Low52	0.68
Low52 Date	2025-12-31
Low52ch	23.35%
Ma50ch	5.11%
Price vs 200-day SMA	-29.81%
RSI	52.15
RSI Monthly	35.42
RSI Weekly	35.13
Sharpe ratio	-1.14x
Sortino ratio	-1.52
Total Return	-18.12%
Tr YTD	-7.82
Tr1m	11.84%
Tr1w	-5.5%
Tr3m	-5.03%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-8M
Operating Income Growth Q	-50.77
Operating margin	-9.44

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	37,424,555%
Float Percent	72.79%
Net Borrowing	-10,041,020.3
Shares Insiders	26.19%
Shares Institutions	1.62%
Shares Out	51,412,120
Shares Qo Q	29.17%
Shares Yo Y	18.12%
Short Float	0.02%
Short Ratio	0.34
Short Shares	0.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$3.8M
Average Volume	48,390.35x
Bv Per Share	2.42
CAPEX	$-1.1M
Ch1m	11.84
Ch1w	-5.5
Ch1y	-47.58
Ch3m	-5.03
Ch3y	-63.05
Ch5y	-86.89
Ch6m	-37.87
Change	-0.26%
Change From Open	-3.01
Close	0.84
Days Gap	2.83
Depreciation Amortization	5,911,065.1
Dollar Volume	8,983.9
Earnings Date	2026-04-30
Earnings Time	amc
EBIT	$-8M
EBITDA	$-2.6M
EPS	$-0.21
F Score	3
FCF	$4.6M
FCF EV Yield	4.92x
FCF Per Share	$0.09
Financing CF	-14,635,508
Fiscal Year End	December
Founded	1,994
Goodwill	77,482,936.9
Income Tax	$-2.3M
Investing CF	-624,529
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2025-06-30
Last Split Type	Never
Last10k Filing Date	2026-04-30
Ma150	1.07
Ma150ch	-21.68%
Ma20	0.82
Ma20ch	1.86%
Net CF	-9,991,217
Next Earnings Date	2026-10-07
Open	0.86
Optionable	Yes
P FCF Ratio	10.37
P OCF Ratio	9
Position In Range	0
Post Close	0.84
Postmarket Change Percent	-1.99
Postmarket Price	$0.82
Ppne	36,210,272.3
Price Date	2026-05-08
Ptbv Ratio	0.85
Relative Volume	0.22x
Revenue	84,755,332x
SBC By Revenue	0.9x
Share Based Comp	761,920
Tax By Revenue	-2.71x
Tr6m	-37.87%
Volume	10,710.4

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does INCR pay a dividend?

Capital-return profile for this ticker.

Performance

INCR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns INCR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.6%

Float: +72.8% of shares outstanding

Insider ownership

+26.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

INCR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.1

Neutral momentum band

Price vs 200-day MA

-29.8%

50/200-day relationship not available

Beta (5Y)

0.33

Less volatile than the market

Sharpe ratio

-1.14

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About INCR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current INCR stock rating?

InterCure Ltd. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full INCR analysis?

The full report lives at /stocks/INCR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for INCR?

The latest report frames INCR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the INCR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.